TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: % time pH < 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Symptom frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of return to HIV care
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Pain reduction after laparoscopic cholecystectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate success of procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction regarding post-operative swelling
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: functional well-being
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Predictive model for liver histology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal Residual Disease (MRD) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily self-reporting rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HAMD-17 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep Score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Success of stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric emptying onset time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastric emptying completion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Perceived benefits of information sharing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevention of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: degree of low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distal contractile integral of primary peristalsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in direct bilirubin at Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in total bilirubin at Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Patient satisfaction with telemedicine services
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of diagnoses considered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proper opioid disposal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analgesic strategies quiz score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Exposure duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Patient satisfaction with telehealth sessions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Comfort during telehealth sessions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Confidence in telehealth participation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Severity of health anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: awareness rate of T. solium taeniasis and cysticercosis control knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to regain birthweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver-reported PedsQL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Child-reported PedsQL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: posteromedial displacements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rotatory laxity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: ischemic cardiovascular events
Endpoint domain: Mortality/survival
Primary endpoint: Postprandial myofibrillar protein synthesis rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma essential amino acid concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient-specific disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: CHD total knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: superiority of vessel preparation strategy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Interest in participation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fear-conditioned SCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: beta-cell function parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: amount of feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: consistency of feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Sleep Regularity Improvement
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Tendon friction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion with ≥1-point improvement in clinical status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of infants at high-risk for obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: phosphorylated AKT (pAKT) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical benefit of ipatasertib
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived benefits of mock interviews
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: hangover frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune indicator
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rates of post-stroke depression (PSD) at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improvements in measured MADs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean daily minutes of moderate to vigorous physical activity (MVPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life post-intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SNF/IRF admissions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach normal HR and RR baseline values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Improvement in CRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: early-PJI incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Ease of intubation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incident heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Atrial fibrillation risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite endpoint of myocardial infarction or cardiovascular death
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: VFSS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: patients' recovery time from intervention to eating mushy food
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: plasma levels of MDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: expression level of miR-146a
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subsequent myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Nursing satisfaction degree
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Placebo-corrected change in blood pressure from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: target lesion late lumen loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-efficacy for health behaviors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Iron solubility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Iron dialyzability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Iron bioavailability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Harris hip function score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: motor function recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KYN/TRP ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAS-28-CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum total plasma concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the curve (AUC0‐8)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: office diastolic blood pressure (oDBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: use of antihypertensive drugs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Baroreflex effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain NRS improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC Pain subscore improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC Function subscore improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma glucose (PG) level during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Activity pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visual analog scale satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of eyes with ≥20/20 UDVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in low-contrast visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vocational hope
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Nasal obstruction resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-expansion maximum velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anatomic failure following prolapse repair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean titers for influenza strains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rates for influenza strains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: diagnostic confidence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: VAS scores in resting state after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores in active state after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for parecoxib within 72 hours after surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: distance traversed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ISGA success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPS success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reoperation risk
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: quit rates at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: high-contrast visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: in vivo wettability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: breastfeeding appreciation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: breastfeeding presence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: breastfeeding responsiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Yale‐Brown Obsessive‐Compulsive Scale (Y‐BOCS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton Anxiety Scale (HAMA) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton Depression Scale (HAMD) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum uric acid (SU) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Daily pain (VAS scores)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Gout recurrent rate
Endpoint domain: Adverse events/effects
Primary endpoint: Nodal efficiency in the anterior prefrontal cortex during encoding phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Nodal efficiency and degree centrality of orbitofrontal cortex during retrieval phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Temporal correlational interactions between dorsolateral prefrontal cortex and anterior prefrontal cortex during episodic memory encoding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: HF prevalence and incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived cognitive abilities
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Quality of life related to cognition (FACT‐Cog QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 12-month incidence of primary patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of primary sustained clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe postoperative complications grade ≥ IIIb
Endpoint domain: Adverse events/effects
Primary endpoint: Severe acute malnutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean drug consumption per hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Requirement for bolus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk mobility improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standing balance improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic stability improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean proportion of adherent days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sets of adherent puffs/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence for ≥80% of study days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma PAI-1 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mortality rate on day 7
Endpoint domain: Mortality/survival
Primary endpoint: Mortality rate at discharge
Endpoint domain: Mortality/survival
Primary endpoint: endorsement of coercive policies
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: intent to discriminate against PLWH
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall recognition memory impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specific recognition memory impairment for negative objects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peridevice leak rate at transesophageal echocardiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: major procedure-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: clinical outcomes at 45 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse evolution rate
Endpoint domain: Adverse events/effects
Primary endpoint: Neurological deficits improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: incidence of severe intraventricular hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: mean airway pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Celiac Disease (CD) development risk
Endpoint domain: Mortality/survival
Primary endpoint: visual acuity in the preferred eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Harris scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Significant new morbidities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of admissions to intensive care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posterior capsule rupture rates
Endpoint domain: Adverse events/effects
Primary endpoint: Cataract surgical procedures performed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Assessment rubric score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: IFN‐γ responses to heterologous stimulants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: MCP‐1 responses to heterologous stimulants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total mismatching rate of SNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GAD score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: addictive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: couple adjustment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: life stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Linkage to care among HIV-positive men
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drilling precision
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: reduction in swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: appearance concern
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Evidence-based prevention strategies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemoglobin (Hb) response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to occurrence of hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: bioequivalence criteria (AUCt and AUC∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-12 physical component scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Risk for LOAD per one-SD increase in genetically predicted CSF p-tau
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Fugl–Meyer assessment (FMA) of the wrist and hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative probability of discontinuing AS at 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resting FBF at 3 hr and 6 hr postmeal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of pocket hematomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: incidence of adverse skin reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Corneal sensitivity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: OSDI questionnaire score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cumulative hazard of successful discontinuation from mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of moderate-severe CRBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to clinic recording of hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes